MiniMed Group Inc (MMED)

NASD · Healthcare · Medical Instruments & Supplies · USA

MiniMed Group Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.

MiniMed develops, manufactures, and markets integrated diabetes management solutions for patients requiring intensive insulin therapy, including automated insulin delivery systems with insulin pumps and continuous glucose monitors, as well as smart multiple daily injection systems. The company serves patients worldwide through healthcare providers including endocrinologists and primary care physicians, operating manufacturing facilities in California and Puerto Rico.

From its FY2026 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the MiniMed Group Inc stock.

Our verdict on MMED

Not valued: We cannot value this company yet.

ETFs with the most weight in MMED

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than MMED in Medical Instruments & Supplies

23 more in this industry show a wider margin of safety.

Is MMED undervalued or overvalued?

We do not publish a verdict on MMED yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of MMED?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.